Our data suggest that an approach based on extending the intravenous multimodal analgesia after discharge has proven to be feasible and appropriate in a wide series of patients in our setting, and in ...
Avenue Therapeutics (ATXI) is developing IV tramadol for postoperative pain. The drug has been approved by the FDA since 1995; however, only in oral form. Avenue has licensed a patented administration ...
Facility-Level Disparities in Radiation Use for Limited-Stage Small Cell Lung Cancer Patient-controlled analgesia (PCA) has been considered for managing cancer pain; however, limited research has been ...
Olinvyk is indicated for short-term intravenous use in hospitals or other controlled clinical settings. The Food and Drug Administration (FDA) has approved Olinvyk (oliceridine; Trevena) for the ...
Announcing a new article publication for BIO Integration journal. In this article the authors Haojie Yang, Yingzhe Yan, Qian Xie and colleagues from Sun Yat-sen University, Guangzhou, China and The ...
Am J Health Syst Pharm. 2007;64(14):1492-1499. Although operator errors were less frequent than device malfunctions, these events were associated with the most severe consequences, including six ...
Please provide your email address to receive an email when new articles are posted on . Avenue Therapeutics announced the FDA has issued a second complete response letter regarding the new drug ...
Trevena announced that the Food and Drug Administration (FDA) has granted Fast Track designation to oliceridine (TRV130) for the management of moderate-to-severe acute pain. Oliceridine is being ...
LONDON, Feb. 5, 2024 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces the launch of COMBOGESIC® IV (acetaminophen and ibuprofen) injection in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback